Mr. Trump plans to speak in the Rose Garden of the White House to an audience that includes members of Congress and patients who have suffered because of high drug costs. “Other countries use socialized health care to command unfairly low prices from U.S. drugmakers,” said a summary provided by the White House on Thursday. Mr. Trump plans to criticize brand-name drug manufacturers for setting high list prices and for trying to stifle competition by delaying the marketing of lower-cost generic drugs. Mr. Trump has repeatedly said that drug companies are “getting away with murder.”In his State of the Union address in January, he said that “fixing the injustice of high drug prices” was one of his top priorities for 2018. “Watch.”As a presidential candidate, Mr. Trump supported two ideas that are anathema to the pharmaceutical industry: allowing Medicare officials to negotiate prices and allowing consumers to import prescription drugs from Canada and certain other countries where brand-name drug prices are generally lower than in the United States.

Source: New York Times May 11, 2018 00:23 UTC